Probleme und Gefahren in den Lieferketten für Arzneimittel

This procedure addresses the problems and dangers within the supply chains for medicines. It seeks to understand the current risks and potential vulnerabilities that could affect the availability of essential drugs. This inquiry affects patients, healthcare providers, and pharmaceutical companies. It aims to identify potential disruptions and ensure a stable supply of medicines for public health.